Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.
Gordon Cummins
Advertisement
Articles by Gordon Cummins
Advertisement
Latest Updated Articles
Refining, Rethinking, and Decentralizing Clinical ResearchPublished: February 26th 2021 | Updated: March 2nd 2021
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5